Cellectar Biosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details 1) - shares	3 Months Ended	12 Months Ended
STOCKHOLDERS' EQUITY (Details 1) - shares	Mar. 31, 2017	Dec. 31, 2016
Number Of Shares Reserved For Future Issuance	9,269,179	12,321,724
Preferred Stock [Member]
Number Of Shares Reserved For Future Issuance	0	1,133,339
Warrant [Member]
Number Of Shares Reserved For Future Issuance	8,760,446	10,716,952
Stock options [Member]
Number Of Shares Reserved For Future Issuance	508,733	471,433